www.weforum.org 11.09.2009 As the global economy begins to exit from the deepest recession since World War II, the recovery is expected to follow a different path from those of recent memory. What, and where, are the new drivers of growth? Marwan M. Boodai, Chief Executive Officer, Boodai Corporation, Kuwait Liu Jiren, Chairman and Chief Executive Officer, Neusoft Corporation, People’s Republic of China; Global Agenda Council on Emerging Multinationals Deepak Puri, Chairman and Managing Director, Moser Baer, India Iqbal Survé, Executive Chairman, Sekunjalo Investments, South Africa James S. Turley, Chairman and Chief Executive Officer, Ernst & Young, USA Wan Gang, Minister of Science and Technology of the People’s Republic of China Chaired by Victor Halberstadt, Professor of Public Economics, Leiden University, Netherlands; Global Agenda Council on International Monetary Systems
Dalian 2009 – Finding the New Shoots of Growth
Godwin Ethan Marcus – We Are Gone
Utilidad de las vías moleculares – www.cedepap.tv
Vea la entrevista completa sólo en www.cedepap.tv Jeff Porter, Ph.D. Utilidad de las vías moleculares en la búsqueda de nuevos targets Especialidad Bioquímica Director de Developmental & Molecular Pathways del Instituto de Investigación Biomédica de Novartis, EE.UU. -.-.-.-.-.-.-.-.-.-.-.CEDEPAP TV es un canal interactivo de divulgación científica, capacitación, entrenamiento y orientación en temas científicos. Con el compromiso de promover el desarrollo de la ciencia, se dio forma a esta innovadora forma de comunicación. CEDEPAP TV está pensado para favorecer la generación de un espacio en el que los profesionales de Iberoamérica puedan publicar sus trabajos o conocimientos científicos, con lineamientos adecuados, tras ser evaluados por un comité específico, e interactuar con una red de profesionales en pos de la generación de conocimiento. Dr. Pablo Tregnaghi Director CEDEPAP TV
prof.dr.sci. Slobodan Vuki?evi? – Tribina Gornji Grad – video 10/10
Inovativna biomedicina: Centri znanstvene izvrsnosti u Hrvatskoj Znanstvena otkri?a u biomedicini su naj?eš?e primjenjiva. Ako autor u vlastitom otkri?u ne može procijeniti mogu?u primjenu u biomedicini onda ga naziva fundamentalnim. U propozicijama za pisanje projekata Europske unije jedan od najvažnijih uvjeta procjene vrijednosti projekta u podru?ju biomedicine jeste njegova primjenjivost i utjecaj na gospodarstvo EU. Da li u Hrvatskoj postoje uvjet za znanstvena otkri?a u biomedicini koja mogu utjecati na razvoj gospodarstva? Koji su to centri izvrsnosti koji imaju istraživa?ki potencijal otkri?a inovativnih biomedicinskih proizvoda? To su pitanja na koja ?u pokušati odgovoriti u svom izlaganju.